Macquarie Group’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-6,996
| Closed | -$31K | – | 2033 |
|
|
2022
Q3 | $31K | Sell |
6,996
-427
| -6% | -$1.89K | ﹤0.01% | 2068 |
|
|
2022
Q2 | $21K | Hold |
7,423
| – | – | ﹤0.01% | 2291 |
|
|
2022
Q1 | $42 | Hold |
7,423
| – | – | ﹤0.01% | 2193 |
|
|
2021
Q4 | $68K | Sell |
7,423
-1,898
| -20% | -$17.4K | ﹤0.01% | 2063 |
|
|
2021
Q3 | $100K | Buy |
9,321
+5,296
| +132% | +$56.8K | ﹤0.01% | 1981 |
|
|
2021
Q2 | $62K | Hold |
4,025
| – | – | ﹤0.01% | 2114 |
|
|
2021
Q1 | $65K | Sell |
4,025
-1,102
| -21% | -$17.8K | ﹤0.01% | 2009 |
|
|
2020
Q4 | $109K | Hold |
5,127
| – | – | ﹤0.01% | 1851 |
|
|
2020
Q3 | $76K | Buy |
5,127
+800
| +18% | +$11.9K | ﹤0.01% | 1848 |
|
|
2020
Q2 | $64K | Buy |
+4,327
| New | +$64K | ﹤0.01% | 1867 |
|